Genexine Inc. 13D/13G Filings for I-Mab (IMAB)

Genexine Inc. 13D and 13G filings for I-Mab:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-06-21
11:10 am
Sale
2021-05-1913GI-Mab
IMAB
Genexine Inc.8,488,885
4.970%
-2,083,938decrease
(-19.71%)
Filing
2021-02-16
08:01 am
Purchase
2020-12-3113GI-Mab
IMAB
Genexine Inc.10,572,823
6.290%
10,572,823increase
(New Position)
Filing